0 items USD 0.00Search
Your search for "mrrpb5 global united states european union china ozone therapy units market research report 2019" gave back 961 results.
The unprecedented demand of proton therapy for the treatment of cancer has set the stage for the market to move ahead at a rapid pace. It is...
Catalog:
iGATE
July 2017
Price: USD 1,950.00
Indian government has banned the use of Colistin, the last-resort antibiotic in livestock. Its use is widespread in Indian poultry. Such move would...
Rockville Research
February 2019
Price: USD 1,100.00
Nestle India Ltd - Strategy, SWOT and Corporate Finance Report Summary Nestle India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
May 2022
Price: USD 175.00
General Insurance Corporation of India - Strategy, SWOT and Corporate Finance Report Summary General Insurance Corporation of India - Strategy, SWOT...
Catalog:
MarketLine
March 2022
Price: USD 175.00
Asia proton therapy market is anticipated to almost three-fold during the period 2016 – 2022. The number of proton therapy centers is continuously...
Catalog:
iGATE
May 2017
Price: USD 1,450.00
Hotel Leela Venture Ltd - Strategy, SWOT and Corporate Finance Report Summary Hotel Leela Venture Ltd - Strategy, SWOT and Corporate Finance Report,...
Catalog:
MarketLine
November 2022
Price: USD 175.00
Union Bank of India - Strategy, SWOT and Corporate Finance Report Summary Union Bank of India - Strategy, SWOT and Corporate Finance Report, is a...
Catalog:
MarketLine
September 2022
Price: USD 175.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Abbott India Limited is a public listed company and a subsidiary of...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Chemical, Industrial & Pharmaceutical Laboratories, now known as...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Lupin mainly comprise of APIs and...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Ipca Labs was founded by K.B. Mehla and Dr. N.S. Tibrawala in 1949...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The key business segments of Aurobindo Pharma are APIs, Formulations...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. From being an enzyme venture, Biocon successfully emerged as a...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Divis labs are Active Pharma Ingredients,...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Torrent Pharmaceuticals Limited is the 8th largest pharmaceutical...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
